Nutrix has been selected by BaselArea.swiss as one of the six participants in the DayOne Accelerator programme, which caters Digital Health startups promoting the health of children and young people.
Out of the six participants, four will receive non-dilutive funding of 50,000 Swiss francs. All the participants will benefit from BaselArea.swiss, which is providing support by connecting them to a network of potential partners and customers, including the particularly distinguished University Children’s Hospital Basel (UKBB).
A total of 120 startups applied to the competition, and 14 were shortlisted. These companies worked in part with UKBB to develop their business ideas, before six were chosen by a panel of experts from the region to progress to the accelerator. One of the participants is the Basel company Nutrix, which is developing a nanosensor for glucose monitoring in saliva to prevent diabetes.
Further reading:
